Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001786335-26-000002

Chief Financial Officer sold 4,653 shares at $23.77 ($110,602)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Horn Howard · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Sale : show line 1 in the form 10b5-1 −4,653 $23.77 $110,602 105,689 D
Open-market sales · 4,653 sh · avg $23.77 · $110,602
Loading xslF345X06/ownership.xml…